Profiling of gene fusion involving targetable genes in Chinese gastric cancer

BACKGROUND: Approximately half of all new cases of gastric cancer (GC) and related deaths occur in China. More than 80% of patients with GC are diagnosed at an advanced stage, which results in poor prognosis. Although HER2-directed therapy and immune checkpoint inhibitors have been somewhat successf...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zhen-Hua, Zhu, Bo-Wen, Shi, Min, Qu, Yu-Rong, He, Xun-Jun, Yuan, Hong-Ling, Ma, Jie, Li, Wei, Zhao, Dan-Dan, Liu, Zheng-Chuang, Wang, Bao-Ming, Wang, Chun-Yang, Tao, Hou-Quan, Ma, Tong-Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412921/
https://www.ncbi.nlm.nih.gov/pubmed/36160735
http://dx.doi.org/10.4251/wjgo.v14.i8.1528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412921/
https://www.ncbi.nlm.nih.gov/pubmed/36160735
http://dx.doi.org/10.4251/wjgo.v14.i8.1528

Ejemplares similares